Your care team will do everything possible to help prevent an active CMV infection. If your doctor thinks you have a high risk for a new CMV infection or reactivation, they might start preventive antiviral medicines. You may take an antiviral medicine like valganciclovir right after your transplant. You may need to stay on it for some months. The medicine will greatly lower your chance of getting an active CMV infection. But sometimes people get an active CMV infection after stopping these medicines.
If you have never had CMV infection before, your doctors will try to limit the possibility that you pick it up from transplant organs, bone marrow, or stem cells, or from blood or white blood cells that you receive. They will try, if possible, to give you transplants only from CMV negative donors. But sometimes this is not possible.
Other times, your doctor might try to prevent you from having the symptoms of the infection using something called preemptive therapy. In this case, your doctor might want you to have weekly lab tests to see if CMV has become active. In this way, they can find an active infection before you have any symptoms. It allows quicker treatment. That will cut your chance of problems.
Your transplant team also tries to limit your risk for CMV infection by adjusting your immune-suppressing medicines. This is done to find the best balance to maintain your transplanted organ or cells while limiting immune suppression that might increase your risk for CMV.